NCT07130214View on ClinicalTrials.gov

The Effect of Genetic Polymorphisms on the Success of Vital Pulp Therapy

Active, not recruitingOBSERVATIONAL
Enrollment

96

Participants

Timeline

Start Date

May 2, 2025

Primary Completion Date

May 2, 2026

Study Completion Date

November 2, 2026

Conditions
Pulp Exposure, DentalPulp Disease, DentalPulp CapingPulpitisPulpitis - IrreversiblePulpal Inflammation
Interventions
DRUG

Biodentine

Biodentine is used in the treatment of existing dentin damage thanks to active bio-silicate technology.

Trial Locations (1)

Unknown

Ataturk University, Erzurum

All Listed Sponsors
collaborator

Health Institutes of Turkey

OTHER_GOV

lead

Ataturk University

OTHER